Clinical efficacy of first-generation EGFR-TKIs in patients with advanced non-small-cell lung cancer harboring EGFR exon 20 mutations

Clinical efficacy of first-generation EGFR-TKIs in patients with advanced non-small-cell lung cancer harboring EGFR exon 20 mutations

Dan Chen,1 Zhengbo Song,2 Guoping Cheng3 1Department of Cardiothoracic Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 2Department of Chemotherapy, 3Department of Pathology, Zhejiang Cancer Hospital, Hangzhou, People’s Republic of China Purpose: Subsets...

Full description

Bibliographic Details
Main Authors: Chen D, Song Z, Cheng G
Format: Article
Language:English
Published: Dove Medical Press 2016-07-01
Series:OncoTargets and Therapy
Subjects:
Non-small cell lung cancer
Epidermal growth factor receptor
EGFR mutations
Exon20
Tyrosine kinase inhibitor
Online Access:https://www.dovepress.com/clinical-efficacy-of-first-generation-egfr-tkis-in-patients-with-advan-peer-reviewed-article-OTT

Internet

https://www.dovepress.com/clinical-efficacy-of-first-generation-egfr-tkis-in-patients-with-advan-peer-reviewed-article-OTT

Similar Items